Cantabio Pharmaceuticals (AgeTech UK) NeuroTech
Neurodegenerative diseases. CANTABio’s research is focused on reducing the harmful effects of biochemical stress, preventing and slowing resulting diseases through developing novel disease modifying therapeutics for neurodegeneration and metabolic conditions.
Technology:
AgeTech Companies
Industry:
UK AgeTech 2020
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership